Abstract
Glucocorticoids induce hyperglycemia in case of pancreatic alpha- and beta-cell dysfunction. Glucagon-like peptide-1 receptor agonists (GLP-1RA) may prevent steroid-induced hyperglycemia by improving hyperglucagonemia and insulin secretion. An 85-year-old man was treated with oral prednisolone for chronic hypersensitivity pneumonitis, and his glycemic control deteriorated after the initiation of steroid therapy. After the administration of dulaglutide injection, his glycemic control was improved and we could discontinue insulin therapy. Both fasting and postprandial plasma glucagon levels were significantly suppressed by a GLP-1RA, dulaglutide. GLP-1RAs therapy may be a useful strategy for the treatment of steroid-induced hyperglycemia. J Endocrinol Metab. 2018;8(1):10-12 doi: https://doi.org/10.14740/jem491w
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
